Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;56(2):495-501.
doi: 10.1002/ppul.25155. Epub 2020 Dec 3.

NT-proBNP levels and cardiopulmonary function in children with sickle cell disease

Lance Feld  1 , Elizabeth K Fiorino  2 , Banu Aygun  3 , Abena Appiah-Kubi  3 , Elizabeth C Mitchell  4 , Stacey Jackson  5 , Roxana Mehran  5 , Joanna Fishbein  6 , Maria T Santiago  5
Affiliations

NT-proBNP levels and cardiopulmonary function in children with sickle cell disease

Lance Feld et al. Pediatr Pulmonol. 2021 Feb.

Abstract

Patients with sickle cell disease (SCD) are living longer and subsequently more apt to develop cardiopulmonary dysfunction. N-terminal pro-brain natriuretic peptide (NT-proBNP) levels have been used in adults with SCD to assess for pulmonary hypertension and mortality. While the incidence of PH is low in pediatrics, it is reasonable to presume that NT-proBNP levels can be used to assess risk for the development of cardiopulmonary morbidity. We hypothesized that NT-proBNP levels would be increased in patients with SCD compared to age-adjusted healthy children; additionally, these levels would be associated with labs indicative of hemolysis and would demonstrate evidence of obstructive lung disease and cardiac dysfunction. We retrospectively evaluated patients with SCD, 8-18 years old, at a large, tertiary care children's hospital. NT-proBNP levels were assessed in correlation with hemolytic lab work, spirometry, and echocardiographic data. The age group 8-14 years old, 75% of our cohort's population, had a median NT-proBNP of 70 pg/ml, greater than their age-adjusted counterparts (52 pg/ml). NT-proBNP levels were associated with an increased degree of hemolysis when compared with hemoglobin (Hb) (r = -0.43, p < .0001), reticulocyte count (r = .25, p = .01) and lactate dehydrogenase levels (r = .47, p < .0001). An inverse trend was found between NT-proBNP and spirometric data. Finally, a positive correlation was found between NT-proBNP and diastolic left ventricular size (r = .28, p = .047]. The correlations found suggest that NT-proBNP may be used prospectively to identify patients with SCD at increased risk for the development of cardiopulmonary dysfunction.

Keywords: hemolysis; lung function; pulmonary hypertension.

PubMed Disclaimer

References

REFERENCES

    1. NIH. Evidence-based management of sickle cell disease: expert panel report, 2014. National Institutes of Health: National Heart, Lung, and Blood Institute; 2014.
    1. Fitzhugh CD, Lauder N, Jonassaint JC, et al. Cardiopulmonary complications leading to premature deaths in adult patients with sickle cell disease. Am J Hematol. 2010;85(1):36-40.
    1. Knight-Madden J, Greenough A. Acute pulmonary complications of sickle cell disease. Paediatr Respir Rev. 2014;15(1):13-16.
    1. Klings ES, Wyszynski DF, Nolan VG, Steinberg MH. Abnormal pulmonary function in adults with sickle cell anemia. Am J Respir Crit Care Med. 2006;173(11):1264-1269.
    1. Intzes S, Kalpatthi RV, Short R, Imran H. Pulmonary function abnormalities and asthma are prevalent in children with sickle cell disease and are associated with acute chest syndrome. Pediatr Hematol Oncol. 2013;30(8):726-732.

LinkOut - more resources